We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » India Takes Aim at Overpriced Orthopedics, Cardiac Stents

India Takes Aim at Overpriced Orthopedics, Cardiac Stents

May 22, 2015

The Indian government is waging a two-pronged attack on pricey implants, with the National Pharmaceutical Pricing Authority investigating reports of excessively high prices on orthopedic implants while a regional regulator office asks NPPA to look at cardiac stent pricing.

Indian law limits price increases on most medical products to no more than 10 percent of the suggested retail price in any given year. To determine if orthopedics makers violated the policy, NPPA requested detailed information on each product made, imported or marketed—including production and distribution costs, the maximum retail price and the percentage by which the maximum retail price has increased each year since 2013.

Companies charging excessive prices will be required to reimburse the government for the overcharged amount, plus interest, going back to the date of the price increase.

Meanwhile, the Maharashtra FDA is asking NPPA to cap prices on cardiac stents after a probe found markups as high as 700 times the actual cost of the implant.

According to Commissioner Harshadeep Kamble, stent prices are inflated when they are imported into the country and local distributors then sell them to hospitals at a profit margin of up to 125 percent.

Kamble’s charges were based on an investigation of six distributors and seven hospitals in and around Mumbai, Pune and Nasik.

View the notice on pricing of orthopedic implants at www.fdanews.com/05-25-15-pricing.pdf. — Elizabeth Orr

Upcoming Events

  • 21Apr

    CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

  • 12May

    Extractables and Leachables: 101

  • 25May

    How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Sanofi-logo.gif

    Sanofi’s Sarclisa Earns Second EC Clearance for Multiple Myeloma

  • emergency use authorization approved

    Qorvo Biotechnologies Earns EUA for Rapid COVID-19 Antigen Test

  • Withdraws cubes

    Zynteglo Gene Therapy Withdrawn in Germany

  • CE mark

    Empowered Diagnostics Earns CE Mark for Rapid COVID-19 Antigen Test

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing